Puma Biotechnology Inc. (PBYI)
3.35
-0.23 (-6.42%)
At close: Mar 03, 2025, 3:59 PM
3.47
3.43%
After-hours: Mar 03, 2025, 04:01 PM EST
Puma Biotechnology Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Net Income | 30.28M | 21.59M | 2K | -29.13M | -59.99M | -75.59M | -113.58M | -291.95M | -276.01M | -239.28M | -141.97M | -54.66M | -74.35M | -10.23M | -15.98K | -16.84K | -14.08K | -15.09M |
| Depreciation & Amortization | 11.52M | 11.52M | 8.92M | 10.6M | 10.03M | 8.08M | 7.38M | 2.81M | 1.15M | 776K | 627K | 423K | 265K | 10.7K | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 8.24M | 10.25M | 11.83M | 32.63M | 36.58M | 57.33M | 86.94M | 108.73M | 117.26M | 94.93M | 39.15M | 7.52M | 1.41M | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | n/a | -18.3M | -33.6M | 9.94M | 18.2M | 33.48M | 13.56M | 11.98M | 10.31M | -13.88M | 20.49M | -18.54M | 9.59M | -281.1K | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | -4.05M | 1.51M | 7.03M | 7.2M | 1.03M | 9.31M | 289K | -30K | 3.37M | 179K | 192K | 10.21M | 18.69M | 8.09M | -15.98K | -16.84K | -14.08K | -1.41M |
| Deferred Income Tax | -7.08M | n/a | n/a | n/a | n/a | n/a | 5K | n/a | -10K | -32K | 3K | n/a | 12K | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | n/a | -17.85M | -43.58M | -602K | 13.16M | 23.28M | -5.14M | 7.94M | 12.54M | -11.07M | 24.79M | -8.33M | 9.98M | 305.12K | -2.27K | 21.00 | 2.25K | 1.41M |
| Operating Cash Flow | 38.92M | 27.01M | -15.8M | 20.7M | 800K | 22.4M | -24.1M | -172.5M | -141.7M | -154.5M | -77.2M | -55.05M | -44M | -1.83M | -18.25K | -16.82K | -11.83K | -15.09M |
| Capital Expenditures | -56K | -12.64M | -7M | n/a | -20.05M | -306K | -609K | -50.43M | -7.28M | -1.18M | -1.29M | -628K | -1.06M | -692.75K | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | 20M | n/a | 193K | 36K | 15K | -37K | -25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -76.23M | -23.81M | -4.84M | -38.07M | -29.83M | -127.2M | -107.5M | -79.73M | -81.79M | -214.81M | -132.26M | -49.35M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 55.85M | 17.33M | 18.94M | 27.19M | 73.28M | 132.67M | 50.49M | 114.72M | 231.27M | 133.22M | 70.28M | 8.45M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -12.5M | -4K | -19K | -20.1M | 37K | -170K | -15.01M | -4K | -3.1M | -1K | -2K | -138K | -1.05M | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -20.44M | -19.13M | 7.1M | -10.9M | 23.3M | 5.2M | -57.6M | -15.4M | 142.2M | -85.9M | -63.3M | -41.53M | -1.2M | -1.75M | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | -1.5M | n/a | -60.63M | 105M | 50M | n/a | n/a | n/a | n/a | n/a | 150K | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -33.85M | n/a | -277K | -30.43M | 68K | -6.44M | 3.45M | 25.11M | 576K | 28.23M | 6.53M | 2.21M | 45K | 61.79K | 16.3K | n/a | n/a | 16.5M |
| Financial Cash Flow | -33.85M | n/a | 12.2M | -31.9M | 100K | -67.1M | 108.4M | 75.1M | 162.4M | 233.36M | 136M | 2.21M | 129.3M | 56.95M | 16.3K | 19.15K | 10.5K | 16.5M |
| Net Cash Flow | -15.37M | 7.88M | 3.5M | -22.16M | 24.24M | -39.53M | 26.72M | -112.8M | 162.93M | -6.97M | -4.5M | -94.36M | 84.03M | 56.95M | -1.95K | 2.33K | -1.33K | 1.41M |
| Free Cash Flow | 38.86M | 14.37M | -22.8M | 20.7M | -19.25M | 22.09M | -24.71M | -222.93M | -148.98M | -155.68M | -78.49M | -55.68M | -45.06M | -2.52M | -18.25K | -16.82K | -11.83K | -15.09M |